Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04986943 · ClinicalTrials.gov registry record
ABTHERA ADVANCE™ Use Without Wittman Patch
A clinical trial of Necrotizing Pancreatitis, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 3
- Enrollment target
- 1
- Study location
NCT04986943 is a study of Necrotizing Pancreatitis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 3 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04986943, a study of Necrotizing Pancreatitis, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to have improved tension on the abdominal wall that may obviate the need for costly Wittmann patch placement.
Conditions Studied
Interventions
- DEVICE Using ABTHERA Advance without a Wittmann Patch
Study Locations (1)
North Carolina
- Atrium Health - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-10-12 |
| Est. Completion | 2023-03-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04986943
The ClinicalTrials.gov registry entry for NCT04986943 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Necrotizing Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Using ABTHERA Advance without a Wittmann Patch is the first listed.
NCT04986943 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04986943 about?
NCT04986943 is a clinical study titled "ABTHERA ADVANCE™ Use Without Wittman Patch". The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to hav...
What is the current status of trial NCT04986943?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2020-10-12. Estimated completion is 2023-03-14.
What conditions does trial NCT04986943 study?
This clinical trial studies the following conditions: Necrotizing Pancreatitis.
What interventions are being tested in trial NCT04986943?
The interventions under investigation include: Using ABTHERA Advance without a Wittmann Patch (DEVICE).
Who is sponsoring clinical trial NCT04986943?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04986943 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.